Rapport Therapeutics, Inc. RAPP Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Selling General And Administrative Expense by Product | ||||||
| Facility Related And Other | $844K-7.6% | —— | —— | —— | $913K— | |
| General And Administrative Personnel Related Costs Including Stock-Based Compensation | $6.98M+40.8% | —— | —— | —— | $4.96M— | |
| Professional And Consulting Costs | $3.67M+121% | —— | —— | —— | $1.66M— | |
| Research And Development Expense by Product | ||||||
| Other Costs | $1.97M+24.7% | $1.8M+138% | $1.69M+110% | $1.61M+166% | $1.58M+142% | |
| Preclinical Programs External Expenses | $4.29M+32.1% | $4.12M+27.5% | $4.47M+20.3% | $4.72M-16.4% | $3.25M-17.5% | |
| RAP219Program External Expenses | $15.82M+98.7% | $14.76M+90.6% | $8.73M+56.3% | $9.69M+99.9% | $7.96M+104% | |
| Research And Development Personnel Related Costs Including Stock-Based Compensation | $10.64M+56.8% | $9.57M+75.1% | $7.38M+36.0% | $6.67M+45.2% | $6.79M+68.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Rapport Therapeutics, Inc. break its business down?
- Rapport Therapeutics, Inc. (RAPP) reports selling general and administrative expense by product across 3 parts — Facility Related And Other, General And Administrative Personnel Related Costs Including Stock-Based Compensation and Professional And Consulting Costs. Each is extracted from the segment footnotes and tracked over time.
- Where does Rapport Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Rapport Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.